Literature DB >> 22142745

Miscellaneous non-inflammatory musculoskeletal conditions. Haemochromatosis: the bone and the joint.

Pascal Guggenbuhl1, Pierre Brissot, Olivier Loréal.   

Abstract

Genetic haemochromatosis is a hereditary disease characterised by tissue iron overload. In Caucasians it is most often due to homozygous C282Y HFE gene mutation, but other genes may be involved. Without treatment by venesections, patients can develop life-threatening visceral damage such as liver cirrhosis and carcinoma, diabetes or heart failure. This treatment has been remarkably successful in preventing these complications, but patients survive with other symptoms of the disease susceptible to impair, sometimes seriously, their quality of life. This is the case of arthropathy and osteoporosis complicating haemochromatosis. In this chapter, focus has been placed on the rheumatological complications of genetic haemochromatosis.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22142745     DOI: 10.1016/j.berh.2011.10.014

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  16 in total

Review 1.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

Review 2.  Microelements for bone boost: the last but not the least.

Authors:  Giuseppe Della Pepa; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

Review 3.  Iron homeostasis in osteoporosis and its clinical implications.

Authors:  G F Li; Y Z Pan; P Sirois; K Li; Y J Xu
Journal:  Osteoporos Int       Date:  2012-04-14       Impact factor: 4.507

4.  Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo.

Authors:  Lei Wang; Bin Fang; Toshifumi Fujiwara; Kimberly Krager; Akshita Gorantla; Chaoyuan Li; Jian Q Feng; Michael L Jennings; Jian Zhou; Nukhet Aykin-Burns; Haibo Zhao
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

5.  Hemochromatosis: a model of metal-related human toxicosis.

Authors:  Pierre Brissot; Thibault Cavey; Martine Ropert; François Gaboriau; Olivier Loréal
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-15       Impact factor: 4.223

6.  Low-intensity pulsed ultrasound treatment as an alternative to vascular bone graft surgery for a 5-year-long ulnar non-union in a patient with haemochromatosis.

Authors:  Sebastian Daniel Povlsen; Bo Povlsen
Journal:  BMJ Case Rep       Date:  2015-11-03

7.  Effect of C282Y genotype on self-reported musculoskeletal complications in hereditary hemochromatosis.

Authors:  António Camacho; Thomas Funck-Brentano; Márcio Simão; Leonor Cancela; Sébastien Ottaviani; Martine Cohen-Solal; Pascal Richette
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 8.  Chronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesis.

Authors:  Laura Toxqui; M Pilar Vaquero
Journal:  Nutrients       Date:  2015-04-02       Impact factor: 5.717

9.  Genetic influences on hand osteoarthritis in Finnish women--a replication study of candidate genes.

Authors:  Satu Hämäläinen; Svetlana Solovieva; Tapio Vehmas; Katariina Luoma; Päivi Leino-Arjas; Ari Hirvonen
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

10.  Low-field magnetic resonance imaging or combined ultrasonography and anti-cyclic citrullinated peptide antibody improve correct classification of individuals as established rheumatoid arthritis: results of a population-based, cross-sectional study.

Authors:  Jens K Pedersen; Tove Lorenzen; Bo Ejbjerg; Marcin Szkudlarek; Anne Voss; Mikkel Østergaard; Anders J Svendsen; Lis S Andersen; Kim Hørslev-Petersen
Journal:  BMC Musculoskelet Disord       Date:  2014-08-07       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.